Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis

被引:156
|
作者
Mizuhara, H
Uno, M
Seki, N
Yamashita, M
Yamaoka, M
Ogawa, T
Kaneda, K
Fujii, T
Senoh, H
Fujiwara, H
机构
[1] OSAKA UNIV,SCH MED,CTR BIOMED RES,SUITA,OSAKA 565,JAPAN
[2] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,KASHIMA YODOGAWA,JAPAN
[3] FUJISAWA PHARMACEUT CO LTD,PHARMACOL RES LABS,KASHIMA YODOGAWA,JAPAN
[4] OSAKA CITY UNIV,SCH MED,DEPT ANAT 2,OSAKA 545,JAPAN
关键词
D O I
10.1053/jhep.1996.v23.pm0008675184
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A single intravenous injection of concanavalin A (Con A) induces T-cell activation and an acute hepatitis in mice. This study investigated the role of interferon gamma (IFN-gamma) in the pathogenesis of this hepatitis model. Striking increases in the plasma levels of various cytokines, including tumor necrosis factor (TNF), interleukin-2 (IL-2), and IFN-gamma, were detected before the increase in plasma aminotransferase levels induced by Con A injection. TNF levels peaked within 2 hours, whereas IFN-gamma levels peaked at 6 hours after Con A injection. In contrast to a sharp peak of TNF levels, high IFN-gamma levels were detected for a more prolonged period. Passive immunization with anti-IFN-gamma monoclonal antibody (MAb) conferred a dose-dependent protection against liver injury in this model. This protection was observed when anti-IFN-gamma MAb was administered at least 30 minutes before Con A injection but not when given 1 hour after Con A injection. The protection from Con A-induced hepatitis was also induced by administration of rIL-6 before Con A injection. rIL-6 treatment induced significant albeit incomplete inhibition of IFN-gamma and TNF production, whereas this regimen did not affect IL-2 production. Despite striking protective effects of rIL-6 or anti-IFN-gamma MAb, comparable levels of cellular (both T cell and polymorphonuclear cell) infiltration were detected in liver sections from animals untreated, or treated with either rIL-6 or anti-IFN-gamma MAb. Moreover, electron microscopic examination showed that infiltrating T cells exhibited a blastoid appearance in all groups. These results indicate that IFN-gamma plays a critical role in the development of Con A-induced acute hepatitis and suggest that IL-6 administration can regulate the manifestation of hepatitis through mechanisms including the reduced production of inflammatory cytokines such as IFN-gamma.
引用
收藏
页码:1608 / 1615
页数:8
相关论文
共 50 条
  • [31] PHOSPHORYLATION OF T-CELL ANTIGEN RECEPTOR-ASSOCIATED PROTEINS - CORRELATION WITH ACTIVATION FOR KILLING AND OR FOR GAMMA-INTERFERON PRODUCTION BY A CYTOLYTIC T-CELL CLONE
    BOYER, C
    LANGLET, C
    GUIMEZANES, A
    BUFERNE, M
    HUA, C
    SCHMITTVERHULST, AM
    ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1987, 138 (01): : 65 - 82
  • [32] Single nucleotide polymorphisms in the interferon-γ and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus
    Abbott, WGH
    Rigopoulou, E
    Haigh, P
    Cooksley, H
    Mullerova, I
    Novelli, M
    Winstanley, A
    Williams, R
    Naoumov, NV
    LIVER INTERNATIONAL, 2004, 24 (02) : 90 - 97
  • [33] Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B
    Otano, Itziar
    Suarez, Lester
    Dotor, Javier
    Gonzalez-Aparicio, Manuela
    Crettaz, Julien
    Olaguee, Cristina
    Vales, Africal
    Ignacio Riezu, Jose
    Larrea, Esther
    Borras, Francisco
    Benito, Alberto
    Hernandez-Alcoceba, Ruben
    Menne, Stephan
    Prieto, Jesus
    Gonzalez-Aseguinolaza, Gloria
    HEPATOLOGY, 2012, 56 (02) : 474 - 483
  • [34] High circulating levels of interleukin-6 and tumor necrosis factor-α are associated with hepatitis B virus clearance during alpha interferon treatment
    Ma, Y
    Hussain, MJ
    D'Antiga, L
    Cheeseman, P
    Williams, R
    Mieli-Vergani, G
    Vergani, D
    HEPATOLOGY, 1999, 30 (04) : 345A - 345A
  • [35] Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
    Chen, Xiao
    Das, Rupali
    Komorowski, Richard
    Beres, Amy
    Hessner, Martin J.
    Mihara, Masahiko
    Drobyski, William R.
    BLOOD, 2009, 114 (04) : 891 - 900
  • [36] ACCESSORY FACTORS INVOLVED IN MURINE T-CELL ACTIVATION - DISTINCT ROLES OF INTERLEUKIN-6, INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR
    VINK, A
    UYTTENHOVE, C
    WAUTERS, P
    VANSNICK, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (01) : 1 - 6
  • [37] The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C
    Cachem, Fabio C. O. F.
    Dias, Aleida S.
    Monteiro, Clarice
    Castro, Jose Roberto
    Fernandes, Gabriel
    Delphim, Leticia
    Almeida, Adilson J.
    Tavares, Felipe
    Maciel, Alessandra M. A.
    Amendola-Pires, Marcia M.
    Brandao-Mello, Carlos E.
    Bento, Cleonice A. M.
    IMMUNOLOGY, 2017, 151 (02) : 167 - 176
  • [38] Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy
    Nishimura, M
    Matsuoka, M
    Maeda, M
    Mizuta, I
    Mita, S
    Uchino, M
    Matsui, M
    Kuroda, Y
    Kawakami, H
    Kaji, R
    Adachi, A
    Uchiyama, T
    HUMAN IMMUNOLOGY, 2002, 63 (08) : 696 - 700
  • [39] Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma
    Feldmann, Georg
    Nischalke, Hans Dieter
    Nattermann, Jacob
    Banas, Brigitte
    Berg, Thomas
    Teschendorf, Christian
    Schmiegel, Wolff
    Duehrsen, Ulrich
    Halangk, Juliane
    Iwan, Agathe
    Sauerbruch, Tilman
    Caselmann, Wolfgang H.
    Spengler, Ulrich
    CLINICAL CANCER RESEARCH, 2006, 12 (15) : 4491 - 4498
  • [40] Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta
    Chalupa, Pavel
    Davidova, Alzbeta
    Beran, Ondrej
    Arientova, Simona
    Bostik, Pavel
    Kapla, Jaroslav
    Kondelkova, Katerina
    Plisek, Stanislav
    Holub, Michal
    APMIS, 2016, 124 (08) : 711 - 718